ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

EARL MAHAFFEY M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 315 out of 676

$325K Total Retail Price of All Prescriptions

Rank: 328 out of 676

287 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

28% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 4,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 310 147 S3 1 1
LISINOPRIL 227 168 2 5
AMLODIPINE BESYLATE 188 150 3 3
OMEPRAZOLE 183 131 4 2
FUROSEMIDE 178 122 5 4
METFORMIN HCL 149 120 6 8
GABAPENTIN 148 88 7 10
SIMVASTATIN 142 116 8 6
LEVOTHYROXINE SODIUM 136 102 9 7
CARVEDILOL 117 102 10 15
TRAMADOL HCL 116 67 11 19
HYDROCHLOROTHIAZIDE 101 72 12 12
POTASSIUM CHLORIDE 100 80 13 9
ATORVASTATIN CALCIUM 99 70 14 20
NAMENDA 86 80 15 35
CITALOPRAM HBR 82 47 16 17
SERTRALINE HCL 80 52 17 26
DONEPEZIL HCL 78 78 18 24
ZOLPIDEM TARTRATE 76 35 19 21
METOPROLOL TARTRATE 72 43 20 22
DIOVAN 72 31 20 37
TRAZODONE HCL 71 42 22 36
FAMOTIDINE 67 44 23 64
AZITHROMYCIN 59 34 24 39
RANITIDINE HCL 59 46 24 27
NAPROXEN 58 42 26 71
POLYETHYLENE GLYCOL 3350 58 58 26 56
DIOVAN HCT 58 29 26 41
AMLODIPINE BESYLATE-BENAZEPRIL 57 57 29 44
MEGESTROL ACETATE 55 50 R 30 111
METOPROLOL SUCCINATE 52 52 31 14
CARISOPRODOL 50 12 R 32 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.